SNPSplicer: systematic analysis of SNP‐dependent splicing in genotyped cDNAs

Functional annotation of SNPs (as generated by HapMap (http://www.hapmap.org) for instance) is a major challenge. SNPs that lead to single amino acid substitutions, stop codons, or frameshift mutations can be readily interpreted, but these represent only a fraction of known SNPs. Many SNPs are located in sequences of splicing relevance—the canonical splice site consensus sequences, exonic and intronic splice enhancers or silencers (exonic splice enhancer [ESE], intronic splice enhancer [ISE], exonic splicing silencer [ESS], and intronic splicing silencer [ISS]), and others. We propose using sets of matching DNA and complementary DNA (cDNA) as a screening method to investigate the potential splice effects of SNPs in RT‐PCR experiments with tissue material from genotyped sources. We have developed a software solution (SNPSplicer; http://www.ikmb.uni‐kiel.de/snpsplicer) that aids in the rapid interpretation of such screening experiments. The utility of the approach is illustrated for SNPs affecting the donor splice sites (rs2076530:A>G, rs3816989:G>A) leading to the use of a cryptic splice site and exon skipping, respectively, and an exonic splice enhancer SNP (rs2274987:C/T), leading to inclusion of a new exon. We anticipate that this methodology may help in the functional annotation of SNPs in a more high‐throughput fashion. Hum Mutat 27(11), 1129–1134, 2006. © 2006 Wiley‐Liss, Inc.

[1]  Michael Ruogu Zhang,et al.  An alternative-exon database and its statistical analysis. , 2000, DNA and cell biology.

[2]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[3]  X. Estivill,et al.  Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. , 2000, Human molecular genetics.

[4]  E. Buratti,et al.  Splicing Factors Induce Cystic Fibrosis Transmembrane Regulator Exon 9 Skipping through a Nonevolutionary Conserved Intronic Element* , 2000, The Journal of Biological Chemistry.

[5]  Thangavel Alphonse Thanaraj,et al.  ASD: a bioinformatics resource on alternative splicing , 2005, Nucleic Acids Res..

[6]  Francisco E. Baralle,et al.  Genomic variants in exons and introns: identifying the splicing spoilers , 2004, Nature Reviews Genetics.

[7]  J. Shendure,et al.  Single Molecule Profiling of Alternative Pre-mRNA Splicing , 2003, Science.

[8]  Sara G. Becker-Catania,et al.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.

[9]  E. Lander,et al.  Detection of regulatory variation in mouse genes , 2002, Nature Genetics.

[10]  F. Baralle,et al.  Functional studies on the ATM intronic splicing processing element , 2005, Nucleic acids research.

[11]  Dirk Holste,et al.  Single Nucleotide Polymorphism–Based Validation of Exonic Splicing Enhancers , 2004, PLoS biology.

[12]  J. Královičová,et al.  Biased exon/intron distribution of cryptic and de novo 3′ splice sites , 2005, Nucleic acids research.

[13]  J. Hampe,et al.  SGCaller: a program to call and review genotypes measured by sequencing. , 2005, BioTechniques.

[14]  Ravi Sachidanandam,et al.  Intrinsic differences between authentic and cryptic 5' splice sites. , 2003, Nucleic acids research.

[15]  Jochen Hampe,et al.  InSNP: A tool for automated detection and visualization of SNPs and InDels , 2005, Human mutation.

[16]  T A Thanaraj,et al.  Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human. , 2002, Human molecular genetics.

[17]  S. Stamm,et al.  Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors , 2004, Journal of neurochemistry.

[18]  E. Buratti,et al.  An Intronic Polypyrimidine-rich Element Downstream of the Donor Site Modulates Cystic Fibrosis Transmembrane Conductance Regulator Exon 9 Alternative Splicing* , 2004, Journal of Biological Chemistry.

[19]  K. Huse,et al.  Sarcoidosis is associated with a truncating splice site mutation in BTNL2 , 2005, Nature Genetics.

[20]  L. Maquat.  Nonsense-mediated mRNA decay , 2002, Current Biology.

[21]  T. Dörk,et al.  A new type of mutation causes a splicing defect in ATM , 2002, Nature Genetics.

[22]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[23]  D. Baralle,et al.  Identification of a mutation that perturbs NF1 agene splicing using genomic DNA samples and a minigene assay , 2003, Journal of medical genetics.

[24]  Rolf Backofen,et al.  Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.

[25]  E. Buratti,et al.  Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. , 1999, Human molecular genetics.

[26]  D. Cooper,et al.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.

[27]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[28]  S. Brenner,et al.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Brockmöller,et al.  Single nucleotide polymorphism characterization by mRNA expression imbalance assessment. , 2004, Pharmacogenetics.